NovoCure Ltd — Director's Dealing 2020

Sep 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-09-15

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Ordinary Shares	M	103000	$22	Acquired	300632	Direct
2020-09-15	Ordinary Shares	S	103000	$99	Disposed	197632	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-15	Options to Buy Ordinary Shares	$22.0	M	103000	Disposed	2025-10-01	Ordinary Shares (103000.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Danziger.

F2: Fully vested as of the date hereof.